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What’s keeping us awake at night? A number of us are
posing this question to members as part of a series of
telephone surveys the American College of Cardiology
(ACC) is conducting to determine how well the College is
serving its members and what it could be doing better. By
far, the most common reply to this question involves
payment and practice issues (education is high in our minds
but does not seem to be causing us to lose sleep). The
mission of our Advocacy Division is to address these
concerns and assist members in confronting these tough
issues. I would like to fill you in on the current Advocacy
priorities—not enumerate a list of issues we are following
and acting on, as that list is very long. Rather, I would like
to provide an overview of the big-picture goals being
pursued and suggest how our members can partner with
ACC leadership and staff to find solutions to the many
vexing problems facing us today.
Fair payment for our services. A long-standing priority
for the ACC is the issue of fair (not exorbitant) payment for
cardiovascular specialty services. Efforts have traditionally
taken the form of consistent action on national payment
issues, particularly as they relate to Medicare. Now, the
College is seeking to be more systematic in responding to
local payment issues. Information is being broadly and
rapidly distributed through e-mail, listserve and the Internet
to assist ACC members in their dealings with payers.
Helpful information often comes from colleagues around
the country as well as from Heart House.
This is where ACC chapters come in, playing a particu-
larly important role. Like politics, all medical and payment
policy is local. So, when the Wisconsin Medicare carrier
said in 1998 that the Health Care Financing Administra-
tion (HCFA) “would not let” it pay for the “off-label” use of
stents (those not specifically studied by the Food and Drug
Administration [FDA]), the College worked with local
leadership and made use of HCFA’s written policy stating
otherwise. In fact, HCFA states that contractors have the
discretion to cover an unlabeled use as long as it does not
conflict with FDA requirements. Thus, the Wisconsin
carrier ultimately reversed its policy and worked with
chapter leaders and other physicians to determine when
off-label uses of stents would be indicated. This strategy has
the added benefit of developing relationships among the
College’s local representatives and the key decision makers
in their areas.
What can you do? First, know that we are our own best
advocates. As physicians, we can most effectively argue that
a specific procedure, test or treatment must be reimbursed
appropriately. Second, develop relationships with the local
payer representatives in your area. Recently in Tennessee,
the Medicare carrier decided to reimburse for only a
subsequent hospital visit when the cardiologist (or any
specialist) actually provided an initial consult for an in-
patient and proceeded to treat that patient. The carrier’s
rationale was that the attending physician had already done
the initial in-patient visit, and, because it appeared that the
patient’s care had been transferred to the specialist, it was
not a true consult. Thus, representatives of the Tennessee
Chapter met with the carrier’s medical director to explain
why this was viewed as unacceptable to the medical com-
munity. The College also alerted cardiovascular leaders in
other states sharing the same carrier. Again, the carrier’s
medical director reversed the decision. Taking the time to
provide reasoned input—preferably backed by data—to
carrier advisory committees and medical directors in your
area can prove beneficial.
“Fraud and abuse”: flies and sledgehammers. We know
there have been instances of overcoding and undercoding;
however, I believe the overwhelming majority of these cases
has been inadvertent. Purposeful overcoding certainly can-
not be tolerated. However, the analogy of the sledgehammer
and the fly comes to mind. To mix a metaphor, the Office
of Inspector General (OIG) has wielded the sledgehammer
in the china shop and has considered broken dishes as
success. Alas, with all this “success,” more sledgehammers
are on the way. There has been an incredible influx of
funding for the OIG’s efforts. Plus, this issue is politically
popular and is believed to have the potential for huge
savings in health care expenditures. The national budget for
these investigative activities has doubled over the past
several years, and it will double again soon. So far, the
government has seen an excellent “return on its investment.”
At the same time, HCFA is in the process of implementing
its Medicare Integrity Program and is contracting with new
entities to enforce Medicare regulations. The thinking is
that the activities of the Medicare carriers and traditional
peer review are not enough. Thus, the numbers of people
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conducting audits and the dollars devoted to them are
markedly increasing.
This intensified effort has certainly led to physicians
feeling unfairly prosecuted for innocent or unintentional
mistakes, especially at a time when the complexity of the
regulations surrounding Medicare is growing. The College
can, of course, never condone any action that comes close to
fraud; however, it will continue to work with the medical
community to protest inappropriate efforts by the OIG and
others. This is a quintessential “House of Medicine” issue,
and the ACC joins the American Medical Association
(AMA) in attempting to ensure that legislation and regu-
lations targeting fraud are appropriate.
What can you do? First, to the greatest extent that it is
feasible, make a record of every single thing that you do.
Look for an electronic means to help—we need to spend
time with our patients instead of being buried under paper.
Second, if your practice has not already done so, work to
develop a compliance plan. Doing so will go a long way
toward showing your good faith to comply with the thou-
sands of Medicare rules. The College’s 2000 coding manual
will include a chapter that outlines the essential elements of
a compliance plan.
Relative value units (RVUs): The saga continues. Given
the importance of Medicare to cardiovascular specialists and
the tendency for the private sector to adopt the fee schedule
as a benchmark, the College continues its battles for the
RVUs assigned to cardiovascular specialty services. Work on
refining the practice expense component of the fee schedule
is ongoing, and the ACC has and will continue to do
everything in its power to improve the impact on cardiology
and ward off attempts to worsen it.
Because of the existence of a cardiology “pool,” any
practice expense RVU increase means a decrease for all
other cardiovascular services. Just as HCFA left work RVU
changes to be fought for mostly within the medical com-
munity under the AMA’s Relative Value Update Com-
mittee (RUC), it has also left determination of practice
expense RVU updates in large part to the specialties. The
existence of this relatively finite practice expense pie has led
to the need for specialties to work out values within the
specialty before going to a higher authority (the AMA or
HCFA). The College is currently developing a process for
recommending changes in RVUs for cardiovascular services.
This process will likely take the form of a “cardiology RUC”
that will ensure representation from the subspecialty soci-
eties.
Meanwhile, the prospects for enlarging the cardiology
pool have been brightened somewhat by the latest AMA
data (on which the determination of specialty pools was
done), which show a substantial increase in practice costs for
cardiovascular specialists relative to other specialties. The
ACC will advocate that HCFA use these data to update the
system; however, this change is unlikely for 2000 and will be
an uphill battle regardless of the data. HCFA has made it
clear that it is not sure that the AMA’s data will be useful in
the future because physicians who filled out the surveys
knew that the data could be used to determine fees. It will
be our job to argue that the initial data had serious
limitations and that these new data are the best currently
available.
The specifics surrounding HCFA’s overall refinement of
the practice expense values are still unclear. For example, we
are not sure what role the AMA will ultimately play in the
refinement process, given that HCFA is hiring a contractor
to address many of the refinement issues. Please stay tuned
for more information; however, at this point, you should be
prepared for next year’s transition, which will take effect
January 1, 2000, virtually unchanged from what was pro-
jected in 1998. The impact will vary widely based on specific
services, but overall, on average, practice expense payments
to cardiologists are expected to go down ;2%.
Another major effort on the horizon is the second
five-year review of the work relative values contained in the
Medicare fee schedule (yes, it has almost been 10 years).
This review process will entail a critical evaluation of the
values assigned to all codes to identify those that are
considered either severely overvalued or undervalued. The
College will be advocating for changes for those services on
which it receives the most feedback. This process begins in
earnest this fall.
What can you do with respect to the Medicare fee
schedule? If you have not already sent to the ACC Advocacy
Division your recommendations for changes in the work
relative values for specific services, do so immediately. Please
include the specific CPT code that you think needs to be
considered. Second, in making decisions, make assumptions
based on the future, not current, fees.
Grassroots activities. Finally, another ACC Advocacy pri-
ority has been to examine the College’s communications
and educational tools for fostering grassroots activities
among its members. The College has recently acquired
software that will improve its ability to alert selected
members to ongoing issues in Congress and the state
legislatures. The software will enable the College to request
that cardiovascular specialists quickly make targeted con-
tacts with particular members of Congress or state legisla-
tors. Examples of legislation that the enhanced communi-
cations ability will help include the pending patient bill of
rights proposals as well as legislation that would allow
physicians to negotiate contracts collectively with insurers
without having to form or join a union. Our chapters’ ability
to advocate for and enact state legislation will also be
improved by this new software.
Late last year, staff began a weekly update on the ACC’s
Web site, which provides brief synopses of the past week’s
activity. The weekly update contains information on activ-
ities concerning legislation, regulation, insurers and pay-
ment issues. “Advocacy Weekly” is also available by fax or
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e-mail to all members on request (phone: 800-435-9203;
fax: 301-897-8757; e-mail: advocacy@acc.org).
What can you do? Please use the new technologies
available to you to communicate with Heart House as well
as to obtain information from the staff there and your
colleagues around the country. ACC staff rely on you to
keep them informed of how legislation, regulations and
payment policies are affecting the practice of cardiovascular
medicine. Please let them know at advocacy@acc.org. Also,
please respond when asked to write, e-mail or call a member
of Congress, HCFA officials or your state legislature, and
send us a copy. Your contacts make the most difference.
I welcome your thoughts on ACC advocacy efforts.
Please feel free to write to me at Heart House, 9111 Old
Georgetown Road, Bethesda, MD 20814-1699; fax: 301-
897-9745; or e-mail: pres@acc.org.
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